Wegovy fuels sharp rise in use of weight-loss drugs for US youth
Public Health,Children,Obesity And Malnutrition
From the Center
AllSides Media Bias Rating: Center
A small but rapidly growing number of U.S. adolescents began treatment with Novo Nordisk's <NOVOb.CO> weight-loss drug Wegovy last year, a powerful new tool to address record rates of pediatric obesity, according to data shared exclusively with Reuters.
Check for Bias
The AI-powered AllSides Bias Checker instantly reveals the bias of a news article. Tap the button to use.
Related Coverage
AllSides Picks
Headline Roundup
CDC Declares End to Cyclospora Outbreak Despite Ongoing Investigations
September 11th, 2026
Headline Roundup
Are Food Recalls Really on the Rise?
September 8th, 2026
News
What the Media Missed: Children Recovered, Heat Deaths Soared, and More
Malayna J. Bizier
September 12th, 2026
Recommended Reading
‘It Absolutely Changed My Life’: How a Conflict-ridden ‘Dirtball’ Became a Legendary Bridge Builder
Braver Angels
September 2nd, 2026
